Scaling Home-Based Diagnostics in Decentralized Healthcare

Overview:

• The global healthcare ecosystem is rapidly shifting toward decentralized care models, with home-based diagnostics emerging as a key pillar. This trend supports chronic care management, reduces hospital load, and empowers patients.
• Demand for at-home testing is growing due to post-COVID behavioral shifts, provider shortages, and the rise of telemedicine platforms.
• Innovations in POC diagnostics, digital enrollment tools, and wearable-enabled monitoring are facilitating remote, patient-centric diagnostic experiences.

Market Size & Growth 

• The global at-home testing market is projected to reach USD 11.88 billion by 2035, up from USD 7.79 billion in 2025, achieving a CAGR of ~4.8%.
• The broader Point-of-Care (POC) diagnostics market is projected to reach USD 68.5 billion by 2030, up from USD 47.8 billion in 2024, with a CAGR of ~5.8%.
• Nova One estimates a sharp rise in the primary care POC market, projecting USD 213.16 billion by 2034 from a base of USD 27.25 billion in 2024, reflecting a CAGR of ~22.8%.

Key Growth Drivers

• The growing global burden of chronic diseases and aging populations are driving demand for early, continuous, and decentralized testing options.
• Patient preference for convenience, privacy, and access has accelerated the shift toward home-based diagnostics post-pandemic.
• Government policies and payer incentives are increasingly aligned with decentralized, cost-effective testing that reduces hospital burden.

M&A Overview

• The sector has seen rising interest from private equity and strategic acquirers, especially in enabling platforms that offer scalability, regulatory compliance, and data integration capabilities.
• Deals are consolidating the fragmented POC and home diagnostics space, particularly in telehealth-integrated diagnostics.
• Startups with digital enrollment, AI-driven analytics, and chronic disease alignment are key M&A targets due to their data defensibility and remote care enablement.

AI’s Role

• The AI-enabled diagnostics is projected to reach USD 10.28 billion by 2034, rising from USD 1.61 billion in 2024, reflecting a CAGR of ~20.4%.
• AI is increasingly used to harmonize data from EHRs, wearables, and apps—supporting real-time triage and diagnostic accuracy.
• AI’s predictive analytics tools help flag disease progression earlier, reducing emergency episodes and improving chronic care outcomes.

Competitive Landscape

• Clario and other digital-first POC platforms are gaining market share by enabling decentralized clinical trials and FDA-aligned data collection.
• Established diagnostics players are investing in remote patient monitoring and SaaS integrations to remain competitive.
• Startups offering modular, scalable platforms with strong clinical validation and reimbursement alignment are attracting VC and PE funding.

‍

Sources: Future Market Insights, Grand View Research, Nova One Advisor, Coherent Market Insights, Market.us, Biospace, LinkedIn Insights

‍